In order to access this content you must be logged in and have a subscription to Pharmalicensing Intelligence.
Pharmalicensing Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
If you want to find out more about the company visit RANIER Technology profile.
CULS Conversion and Additional Listing
OXIS International, Inc. (OXIS) Announces the Launch of Oxis Consumer Products Subsidiary
Omnicare Announces Acquisition of Continuing Care Rx
US Educational Support Service for MS Community, MS LifeLines
Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP
LGC and China Association for Standardisation sign Memorandum of Understanding
The Gamida Cell-TEVA Joint Venture Receives FDA Fast Track Designation for StemEx